DOMO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
DOMO is not a good buy right now for a beginner long-term investor with $50,000-$100,000 available. The stock has some short-term technical strength, but the overall setup is weak because analyst sentiment has deteriorated, there is no fresh news catalyst, and the latest business update included debt covenant pressure and ongoing strategic transaction uncertainty. For an impatient investor who does not want to wait for a better entry, this is still not an attractive long-term purchase today.
DOMO is in a short-term rebound phase but not a strong long-term buy setup. The MACD histogram is positive and expanding, which supports near-term momentum. However, RSI_6 at 70.587 is stretched, moving averages are converging, and price at 3.515 is below the recent resistance zone around 3.437 to 3.823, suggesting limited upside before friction. The pattern data also points to weaker forward returns, with a 60% chance of declines over the next day, week, and month. Overall trend: mildly bullish short term, but not convincing enough for a beginner long-term entry.
["MACD histogram is positive and expanding, indicating improving short-term momentum.", "Options flow is heavily call-skewed, which suggests bullish trading sentiment.", "Cantor Fitzgerald still keeps an Overweight rating despite lowering the price target.", "Q1 reportedly showed better-than-expected profitability and improved retention metrics."]
["Domo breached a loan covenant by missing the required annual recurring revenue threshold, creating debt pressure.", "Lenders have the right to demand immediate repayment of the $137M debt, although temporary forbearance was granted.", "Strategic transaction timing remains uncertain, and the company is under sale-process pressure.", "Analyst targets were sharply cut across firms, including TD Cowen, Citizens, and Cantor Fitzgerald.", "No recent news in the past week to provide a fresh upside catalyst.", "Insiders and hedge funds are neutral, with no meaningful accumulation trend.", "Pattern analysis suggests weaker near-term performance probabilities."]
Latest quarter: Q1. The quarter was mixed, with slightly weaker revenue and subscription revenue/billings missing estimates, but profitability was better than expected and retention metrics improved. The bigger issue is balance-sheet stress: the company missed its ARR covenant threshold and entered a forbearance agreement with lenders, which overshadows the operating improvements.
Analyst sentiment has turned more cautious. Cantor Fitzgerald lowered its target to $5 from $8 but kept Overweight. Citizens cut its target to $2.25 from $3.50 and kept Underperform, highlighting covenant breach and going-concern concerns. TD Cowen downgraded the stock to Hold from Buy and reduced its target to $3.25 from $6. Stephens also cut its target to $8 from $18, though it remained Overweight. Overall, Wall Street is split, but the recent direction is clearly bearish on price targets and more cautious on the name.
